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 Transforming growth factor-β (TGF-β) plays an important role in the pathogenesis of 
variable diseases. However, precise mechanisms how TGF-β regulates immune responses in 
autoimmune diseases and cancers still remain largely unknown. The purpose of this thesis is to 
clarify the molecular mechanisms how TGF-β signaling regulates Th17 differentiation in 
rheumatoid arthritis and how TGF-β antagonism enhances anti-melanoma cytotoxic T 
lymphocytes (CTL) differentiation and function. 
 
<Material and Methods> 
 1. Collagen-induced arthritis (CIA) model was applied to T cell-specific/inducible systemic 
Smad2 conditional knockout mice and Smad3 heterozygote mice in vivo. Wild type, Smad2-/- or 
Smad3-/- CD4+ T cells were cultured under Th17-polarizing condition with IL-6 and TGF-β in 
vitro.  




(75 mg/kg bid) were orally administered to C57BL/6 mice and T cell-specific Smad4 
knockout/control wild type micethat had been innoculated with B16F1 melanoma. Smad4-/- and 
Smad4+/+ CD8+ T cells were stimulated with anti-CD3 (1.0 μg/ml) and anti-CD28 (3.0 μg/ml) 
antibodies in vitro. 
 
<Results> 
1. Smad2 and Smad3 had opposing functions as transcription cofactors of STAT3 in Th17 
differentiation. TGF-β/TCR/IL-6-phosphorylated-ERK phosphorylated Smad2 linker at the 
serine 255 residue, which acts as STAT3 coactivator in cooperation with p300 to enhance Th17 
differentiation. By contrast, unphosphorylated Smad3 acts as STAT3 corepressor by making a 
complex with PIAS3 to suppress Th17 differentiation. 
2. Systemic ALK5 inhibition suppresses melanoma by inducing ubiquitin-mediated 
degradation of Smad4 in addition to inhibiting Smad2/3 phosphorylation in CD8+ T cells, 
thereby derepressing anti-melanoma CTL activity. 
 
<Discussion> 
  This thesis reports the novel mechanisms how homologous TGF-β receptor-Smads 
distinctively regulate Th17 differentiation by networking with IL-6 and TCR signaling 
pathways.  In addition, this thesis reports the novel mechanisms of action how ALK5 inhibitor 
enhances CTL activity. These findings also show that SMAD-mediated TGF-β signaling 




 本論文は Th17細胞分化に関与する TGF-βのシグナル伝達ネットワークの詳細と、TGF-βシグナ
ルを制御することによって悪性黒色腫の増殖を抑制する分子機構を世界で初めて明らかにした論
文で、きわめて質の高い研究成果である。 
平成２８年２月２３日、学位論文審査委員会において、審査委員全員出席のもと論文について説
明を求め、関連事項について質疑応答を行い、最終試験を行った。その結果、審査委員全員が合格
と判定した。 
よって、著者は博士（医学）の学位を受けるのに十分な資格を有するものと認める。 
